NON-FINANCIAL FACTORS OF PHARMACEUTICAL COMPANIES’ EFFICIENCY IN RUSSIA

Author:

Makushina E. Yu.ORCID, ,Malofeeva T. N.ORCID,Koziorova O. I.ORCID,Andreeva Yu. A.ORCID, , ,

Abstract

The development of the pharmaceutical industry is inextricably linked with the development of new types of drugs, the introduction of new technologies, the provision of scientific research in bioengineering and biotechnology, which can be ensured through the continuous development of intellectual capital. Intellectual capital is a capacious and ambiguous concept that, other things equal, is explained by the presence of professional skills and competencies of employees that cannot be separated from them and, therefore, are reflected in the financial statements. For a long time, researchers have been evaluating the impact of intellectual capital on the performance and value of companies in various sectors of economy. This article attempts to look at the problem more broadly by adding the factors inherent in sustainable development and competitive advantages of the company: business model and business strategy to the traditional elements of intellectual capital. The purpose of the work is to assess 137the impact of business strategy, business model and intellectual capital components on the performance of pharmaceutical companies in Russia. The object of the study is the financial and non-financial reporting of Russian pharmaceutical companies. The subject is establishing the relationship between the disclosure of information on intellectual capital and financial performance, taking into account the business strategy and business model of the company. The methodological basis is the statistical and economic method, namely, the regression of panel data with fixed effects. The results show that most large companies in pharmaceutical sector adhere to the business strategy of “analyzers” and choose the business model of producers of their own drugs. The findings indicate no connection between the company's business strategy and business model and the performance of pharmaceutical companies. Elements of IC have been established that provide competitive advantages for the company in pharmaceutical industry.

Publisher

Moscow University Press

Subject

Electrical and Electronic Engineering,Building and Construction

Reference52 articles.

1. 1. Alcaniz, L., Gomez-Bezares, F., & Roslender, R. (2011). Theoretical perspectiveson intellectual capital: A backward look and a proposal for going forward. Accounting Forum,35(2), 104-117. https://doi.org/10.1016/j.accfor.2011.03.004

2. 2. Ali, M. A., Hussin, N., Haddad, H., Al-Araj, R., & Abed, I. A. (2021). A multidimensional view of intellectual capital: The impact on innovation performance.Journal of Open InnovationTe chnology, Market and Complexity,7(4), 1-25. https://doi.org/10.3390/joitmc7040216

3. 3. Andriessen, D., & Stam, C. (2009). Intellectual capital of the European Union 2008: measuring the Lisbon strategy for growth and jobs.Electronic Journal of Knowledge Management,7(4), 489-500.77https://scholar.google.ru/citations?view_op=view_citation&hl=en&user=zFsxMC4AAAAJ&citation_for_view=zFsxMC4AAAAJ:u5HHmVD_uO8C

4. 4. Baker, R. J. (2008).Mind over Matter: Why Intellectual Capital is the Chief Source of Wealth.John Wiley and Sons Publication. https://www.wiley.com/en-us/Mind+Over+Matter%3A+Why+Intellectual+Capital+is+the+Chief+Source+of+Wealth-p-9780470198810

5. 5. Bartholomew, D. (2009).Building on Knowledge: Developing Expertise, Creativityand Intellectual Capital in the Construction Professions. Wiley Blackwell. https://www.wiley.com/en-in/Building+on+Knowledge%3A+Developing+Expertise%2C+Creativity+and+Intellectual+Capital+in+the+Construction+Professions-p-9781444301410

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3